Literature DB >> 22334652

Context surrounding processing sites is crucial in determining cleavage rate of a subset of processing sites in HIV-1 Gag and Gag-Pro-Pol polyprotein precursors by viral protease.

Sook-Kyung Lee1, Marc Potempa, Madhavi Kolli, Ayşegül Özen, Celia A Schiffer, Ronald Swanstrom.   

Abstract

Processing of the human immunodeficiency virus type 1 (HIV-1) Gag and Gag-Pro-Pol polyproteins by the HIV-1 protease (PR) is essential for the production of infectious particles. However, the determinants governing the rates of processing of these substrates are not clearly understood. We studied the effect of substrate context on processing by utilizing a novel protease assay in which a substrate containing HIV-1 matrix (MA) and the N-terminal domain of capsid (CA) is labeled with a FlAsH (fluorescein arsenical hairpin) reagent. When the seven cleavage sites within the Gag and Gag-Pro-Pol polyproteins were placed at the MA/CA site, the rates of cleavage changed dramatically compared with that of the cognate sites in the natural context reported previously. The rate of processing was affected the most for three sites: CA/spacer peptide 1 (SP1) (≈10-fold increase), SP1/nucleocapsid (NC) (≈10-30-fold decrease), and SP2/p6 (≈30-fold decrease). One of two multidrug-resistant (MDR) PR variants altered the pattern of processing rates significantly. Cleavage sites within the Pro-Pol region were cleaved in a context-independent manner, suggesting for these sites that the sequence itself was the determinant of rate. In addition, a chimera consisting of SP1/NC P4-P1 and MA/CA P1'-P4' residues (ATIM↓PIVQ) abolished processing by wild type and MDR proteases, and the reciprocal chimera consisting of MA/CA P4-P1 and SP1/NC P1'-4' (SQNY↓IQKG) was cleaved only by one of the MDR proteases. These results suggest that complex substrate interactions both beyond the active site of the enzyme and across the scissile bond contribute to defining the rate of processing by the HIV-1 PR.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22334652      PMCID: PMC3339993          DOI: 10.1074/jbc.M112.339374

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  44 in total

1.  Three-dimensional structure of aspartyl protease from human immunodeficiency virus HIV-1.

Authors:  M A Navia; P M Fitzgerald; B M McKeever; C T Leu; J C Heimbach; W K Herber; I S Sigal; P L Darke; J P Springer
Journal:  Nature       Date:  1989-02-16       Impact factor: 49.962

2.  HIV-1 protease specificity of peptide cleavage is sufficient for processing of gag and pol polyproteins.

Authors:  P L Darke; R F Nutt; S F Brady; V M Garsky; T M Ciccarone; C T Leu; P K Lumma; R M Freidinger; D F Veber; I S Sigal
Journal:  Biochem Biophys Res Commun       Date:  1988-10-14       Impact factor: 3.575

3.  Synthetic peptides as substrates and inhibitors of human immune deficiency virus-1 protease.

Authors:  S Billich; M T Knoop; J Hansen; P Strop; J Sedlacek; R Mertz; K Moelling
Journal:  J Biol Chem       Date:  1988-12-05       Impact factor: 5.157

4.  Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone.

Authors:  A Adachi; H E Gendelman; S Koenig; T Folks; R Willey; A Rabson; M A Martin
Journal:  J Virol       Date:  1986-08       Impact factor: 5.103

5.  Cleavage of HIV-1 gag polyprotein synthesized in vitro: sequential cleavage by the viral protease.

Authors:  S Erickson-Viitanen; J Manfredi; P Viitanen; D E Tribe; R Tritch; C A Hutchison; D D Loeb; R Swanstrom
Journal:  AIDS Res Hum Retroviruses       Date:  1989-12       Impact factor: 2.205

6.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

7.  Crystal structure of a retroviral protease proves relationship to aspartic protease family.

Authors:  M Miller; M Jaskólski; J K Rao; J Leis; A Wlodawer
Journal:  Nature       Date:  1989-02-09       Impact factor: 49.962

8.  A structural model for the retroviral proteases.

Authors:  L H Pearl; W R Taylor
Journal:  Nature       Date:  1987 Sep 24-30       Impact factor: 49.962

9.  Activity of purified biosynthetic proteinase of human immunodeficiency virus on natural substrates and synthetic peptides.

Authors:  H G Kräusslich; R H Ingraham; M T Skoog; E Wimmer; P V Pallai; C A Carter
Journal:  Proc Natl Acad Sci U S A       Date:  1989-02       Impact factor: 11.205

10.  Effective blocking of HIV-1 proteinase activity by characteristic inhibitors of aspartic proteinases.

Authors:  A D Richards; R Roberts; B M Dunn; M C Graves; J Kay
Journal:  FEBS Lett       Date:  1989-04-10       Impact factor: 4.124

View more
  26 in total

1.  Fullerene Derivatives Strongly Inhibit HIV-1 Replication by Affecting Virus Maturation without Impairing Protease Activity.

Authors:  Zachary S Martinez; Edison Castro; Chang-Soo Seong; Maira R Cerón; Luis Echegoyen; Manuel Llano
Journal:  Antimicrob Agents Chemother       Date:  2016-09-23       Impact factor: 5.191

2.  A two-pronged structural analysis of retroviral maturation indicates that core formation proceeds by a disassembly-reassembly pathway rather than a displacive transition.

Authors:  Paul W Keller; Rick K Huang; Matthew R England; Kayoko Waki; Naiqian Cheng; J Bernard Heymann; Rebecca C Craven; Eric O Freed; Alasdair C Steven
Journal:  J Virol       Date:  2013-10-09       Impact factor: 5.103

3.  Picomolar to Micromolar: Elucidating the Role of Distal Mutations in HIV-1 Protease in Conferring Drug Resistance.

Authors:  Mina Henes; Gordon J Lockbaum; Klajdi Kosovrasti; Florian Leidner; Gily S Nachum; Ellen A Nalivaika; Sook-Kyung Lee; Ean Spielvogel; Shuntai Zhou; Ronald Swanstrom; Daniel N A Bolon; Nese Kurt Yilmaz; Celia A Schiffer
Journal:  ACS Chem Biol       Date:  2019-08-13       Impact factor: 5.100

Review 4.  Highly resistant HIV-1 proteases and strategies for their inhibition.

Authors:  Irene T Weber; Daniel W Kneller; Andres Wong-Sam
Journal:  Future Med Chem       Date:  2015       Impact factor: 3.808

5.  HIV-1 Protease Uses Bi-Specific S2/S2' Subsites to Optimize Cleavage of Two Classes of Target Sites.

Authors:  Marc Potempa; Sook-Kyung Lee; Nese Kurt Yilmaz; Ellen A Nalivaika; Amy Rogers; Ean Spielvogel; Charles W Carter; Celia A Schiffer; Ronald Swanstrom
Journal:  J Mol Biol       Date:  2018-11-07       Impact factor: 5.469

6.  Induced maturation of human immunodeficiency virus.

Authors:  Simone Mattei; Maria Anders; Jan Konvalinka; Hans-Georg Kräusslich; John A G Briggs; Barbara Müller
Journal:  J Virol       Date:  2014-09-17       Impact factor: 5.103

7.  Potential role for CA-SP in nucleating retroviral capsid maturation.

Authors:  Matthew R England; John G Purdy; Ira J Ropson; Paula M Dalessio; Rebecca C Craven
Journal:  J Virol       Date:  2014-04-09       Impact factor: 5.103

8.  Dominant Negative MA-CA Fusion Protein Is Incorporated into HIV-1 Cores and Inhibits Nuclear Entry of Viral Preintegration Complexes.

Authors:  Jordan Anderson-Daniels; Parmit K Singh; Gregory A Sowd; Wen Li; Alan N Engelman; Christopher Aiken
Journal:  J Virol       Date:  2019-10-15       Impact factor: 5.103

9.  Understanding HIV-1 protease autoprocessing for novel therapeutic development.

Authors:  Liangqun Huang; Chaoping Chen
Journal:  Future Med Chem       Date:  2013-07       Impact factor: 3.808

10.  Presentation overrides specificity: probing the plasticity of alphaviral proteolytic activity through mutational analysis.

Authors:  Valeria Lulla; Liis Karo-Astover; Kai Rausalu; Andres Merits; Aleksei Lulla
Journal:  J Virol       Date:  2013-07-17       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.